Probing, Fusion, and Trustworthiness: A Systematic Evaluation of Foundation Model Representations for Multimodal Cancer Analysis

πŸ“… 2026-06-15
πŸ“ˆ Citations: 0
✨ Influential: 0
πŸ“„ PDF
πŸ€– AI Summary
This study evaluates the generalization capability and clinical reliability of foundation models under distribution shifts using multimodal cancer data, specifically whole-slide images and transcriptomic profiles. Through unimodal probing, multimodal fusion, and conformal prediction, the work systematically examines the complementarity between imaging and omics representations and validates the efficacy of fusion strategies in scenarios where no single modality dominates. The results demonstrate that foundation models exhibit robust performance on out-of-distribution data, that multimodal fusion significantly enhances predictive accuracy, and that incorporating conformal prediction substantially improves diagnostic recoverability and clinical trustworthiness.
πŸ“ Abstract
Foundation models (FMs) have emerged as powerful representation extractors for medical data, yet their generalizability to datasets under distribution shift remains underexplored. This work systematically evaluates FM-based representations on a suite of computational pathology tasks across two real-world commercial cohorts, IH-BC and IH-NSCLC, drawn from the licensed in-house (IH) oncology dataset. The analysis focuses on two modalities, whole-slide images and transcriptomic profiles, drawn from the IH multimodal data. We first benchmark unimodal probing performance across five FMs on eight downstream classification tasks, and find that image and omics representations carry complementary predictive signals. Then we investigate whether multimodal fusion can yield additional gains over unimodal baselines by comparing three image-omics fusion strategies built on paired representations. The trustworthiness of selected unimodal and multimodal pipelines is further assessed through conformal prediction. Our results show that FM representations achieve competitive performance on out-of-distribution data and that multimodal fusion helps mainly when no single modality dominates the signal. Conformal prediction reveals that in the majority of cases where a point prediction fails, the true diagnosis remains recoverable within the prediction set, reinforcing the value of uncertainty-aware inference for clinical support.
Problem

Research questions and friction points this paper is trying to address.

foundation models
multimodal fusion
distribution shift
trustworthiness
cancer analysis
Innovation

Methods, ideas, or system contributions that make the work stand out.

foundation models
multimodal fusion
conformal prediction
distribution shift
computational pathology
πŸ”Ž Similar Papers
No similar papers found.
πŸ’Ό Related Jobs
Postdoctoral Fellow – AI-Driven Multi-Omics Integration for Predictive Toxicology
Pfizer
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
Hybrid
Jingyu Hu
Jingyu Hu
University of Bristol
Trustworthy AIExplainabilityFairnessLLMs
G
Giuseppe Tripodi
The Alan Turing Institute, London, United Kingdom; University of Manchester, Manchester, United Kingdom
R
Reed Naidoo
The Alan Turing Institute, London, United Kingdom; The Institute of Cancer Research, London, United Kingdom
S
Sarah F. McGough
Genentech, United States
T
Tapabrata Chakraborti
The Alan Turing Institute, London, United Kingdom